Candida Auris is an emerging multi-drug-resistant fungus with catastrophic consequences. It is rapidly spreading worldwide in healthcare settings and immunocompromised patients are much at risk. Large outbreaks have been reported worldwide and this phenomenon is mainly associated with the increasing rate of invasive procedures, extensive use of broad-spectrum antimicrobials, and more frequent immunocompromised status of critically ill patients. High mortality rates have been associated with therapeutic failure mainly related to Azole Resistance. Difficulty in microbiological identification, high virulence, multi-drug resistance profile, and rapid global spread with several reported outbreaks make C. Auris as one of the serious emerging pathogens that physicians should be aware of. Our Study retrospectively analyzed the Epidemiology, clinical profile, and sensitivity pattern of Candida Auris infection at Max Super specialty Hospital I.P. Extension, Delhi a tertiary care center in North India.